🇨🇳#BREAKING Tencent moves closer to launching AI agent for WeChat’s 1.4bn Chinese users, FT reports.
Tencent Holdings rose sharply in intraday trade, up more than 3%
#CHINA $SHCOMP $SSEC $ASHR $HSI $KWEB $FXI $HXC $DRAG $YINN $YANG #STOCKMARKET#TENCENT $TCEHY #TECH#AI#WECHAT
(https://t.co/hvuqltt408)
SA petrol price to increase by R1.43/l in June while the diesel price will decline by between R3.24/l and R2.61/l. This includes the 50% claw back of the fuel levy subsidy. While not great news, at least there is a reduction in the diesel price, which hopefully continues in July
$TGT | Target Q1 Earnings Highlights
🔹 EPS: $1.71 / Est. $1.46 🟢
🔹 Revenue: $25.44B / Est. $24.66B 🟢
FY Guidance:
🔹 Profit: Sees high end of $7.50-$8.50 range
I spent some quality time today with the $TMDX team at their HQ in Andover, MA.
I’ll share some deeper thoughts over the next few days including my bear case, base case, bull case and super bull case for the next ~6 years… ie through 2032 which is when they expect to hit 30,000+ OCS cases.
Waleed said there’s upside to those targets if several important catalysts play out as hoped/expected… not to mention their 2028/2030/2032 targets of 10k/20k/30k cases don’t include CHOPS which gives them a shot at the ~50% of organ transports/transplants that are still happening with cold storage/preservation.
I came away from today’s meetings even more bullish because my long term investment thesis is even stronger now. I have a better understanding of the catalysts and the European growth strategy as well as the upside potential of becoming an OPO.
It’s pretty clear the market doesn’t fully understand the current/future opportunity to revolutionize organ procurement, transportation and transplantation through OCS, NOP, CHOPS and potentially becoming an OPO.
I also think the market is sleeping on the upside with OCS 2.0, OCS Kidney and OCS 3.0 (which should provide a nice boost to margins through better operational efficiencies).
I have investment models through 2032 for my bear case, base case, bull case and super bull case.
Here are their respective CAGR's through 2032:
Bear case: +17%
Base case: +31%
Bull case: +38%
Super bull case: +48%
I'll consider sharing all the details from these models which includes # of cases in 2032, average revenue/price per case, net income margins, P/E multiple, outstanding share count, net cash/debt and target price (which you could easily reverse engineer using the respective CAGR's that I shared above)
fwiw, my base case implies that $TMDX hits the current 2032 target of 30k cases which should be considered conservative since it doesn't include anything from CHOPS or the upside from $TMDX becoming an OPO.
Too many investors are focused on the short term margin compression while overlooking why it's happening and the growth opportunity it's unlocking for the next 5-10 years.
I'm definitely feeling some pain on our $TMDX position but I'm willing to be patient... because I'm highly confident that we'll be rewarded for that patience over the next 5+ years.
NFA.
DYOR.
*I own $TMDX personally and we have a position at @FirstWaveFund which we added to today after the HQ meetings.
IRAN SEEKS LONG TRUCE, HORMUZ REOPENING IN REVISED PROPOSAL
Leaks cited by Al Arabiya report that Iran is seeking a phased truce and gradual reopening of the Strait of Hormuz in a revised proposal.
Tehran is also said to be open to a long-term freeze of its nuclear program instead of full dismantlement, while proposing that enriched uranium be transferred to Russia rather than the US.
Good Boxer results out today, also good for Pick N Pay as they hold 2/3rds of Boxer. Updating my sum-of-the-parts for PIK and, even after removing c.R2bn incoming loss from their cash pile, the market has discounted them by c.R11bn versus the market price of their Boxer stake: